Therapeutic Asset Ratings

184 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Wilate Hemophilia A	Emory University	P4	B (56)
Ipilimumab Breast Cancer	Emory University	P2	CCC (55)
CIS-DIAMMINEDICHLOROPLATINUM II Solid Neoplasm	Emory University	P1	CCC (55)
Famotidine Multiple Myeloma	Emory University	P4	CCC (54)
Infliximab Schizophrenia	Emory University	P4	CCC (54)
Recombinant Human Granulocyte Colony-Stimulating Factor Multiple Myeloma	Emory University	P4	CCC (54)
Zanidatamab Colorectal Cancer	Emory University	P2	CCC (54)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Cervical Carcinoma	Emory University	P2	CCC (53)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Fallopian Tube Carcinoma	Emory University	P2	CCC (53)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Malignant Solid Neoplasm	Emory University	P2	CCC (53)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Malignant Uterine Neoplasm	Emory University	P2	CCC (53)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Ovarian Carcinoma	Emory University	P2	CCC (53)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Primary Peritoneal Carcinoma	Emory University	P2	CCC (53)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Vulvar Carcinoma	Emory University	P2	CCC (53)
Acalabrutinib Lymphoplasmacytic Lymphoma	Emory University	P2	CCC (53)
Acalabrutinib Lymphoproliferative Disorder	Emory University	P2	CCC (53)
Atovaquone Ovarian High Grade Serous Adenocarcinoma	Emory University	P2	CCC (53)
Atovaquone Platinum-Resistant Ovarian Carcinoma	Emory University	P2	CCC (53)
Avutometinib Advanced Lung Adenocarcinoma	Emory University	P2	CCC (53)
Bendamustine CCND1 Positive	Emory University	P2	CCC (53)
Cyclophosphamide Bladder Adenocarcinoma	Emory University	P2	CCC (53)
Cyclophosphamide Bladder Squamous Cell Carcinoma	Emory University	P2	CCC (53)
Cyclophosphamide Urachal Adenocarcinoma	Emory University	P2	CCC (53)
Defactinib Advanced Lung Adenocarcinoma	Emory University	P2	CCC (53)
DICLOFENAC Advanced Lung Non-Small Cell Carcinoma	Emory University	P2	CCC (53)

Showing 51 to 75 of 184 assets

PreviousPage 3 of 8Next